Skip to main content
. Author manuscript; available in PMC: 2009 Nov 25.
Published in final edited form as: Clin Microbiol Infect. 2009 May;15(5):415–421. doi: 10.1111/j.1469-0691.2009.02785.x

FIG. 3.

FIG. 3

Serum levels of the B-cell chemokine CXCL13 in wild-type and interleukin-10 (IL-10)-deficient mice. Groups of four to eight wild-type (left panel) or IL-10-deficient C57BL/10 (right panel) mice were necropsied at various times after inoculation of serotype 2 of Borrelia turicatae (Bt2), and the serum levels of CXCL13 were measured by ELISA in comparison with uninfected control mice (phosphate-buffered saline (PBS)). Whereas peak bacteraemia occurred in wild-type mice on day 4 and had resolved by day 5, peak bacteraemia was of lower magnitude and occurred earlier in IL-10-deficient mice. Note that production of CXCL13 was ten times higher early on in IL-10-deficient mice (right panel). RF, relapsing fever.